Recent Posts
- Therapeutic targets for ADPKD
- InnoSer completes a major milestone in the HEAL project with validated tumorigenicity assay
- Exploring InnoSer’s Key In vitro Oncology Services: PD-1 PD-L1 Blockade Assay
- InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research
- Invitation: Meet InnoSer at the upcoming Society for Neuroscience 2024 Chicago Meeting